We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BE icon
376
Bloom Energy
BE
$64.6B
$631K 0.06%
26,389
+4,299
+19% +$83.2K
MMYT icon
377
MakeMyTrip
MMYT
$5.64B
$629K 0.06%
6,415
+79
+1% +$7.97K
NVGS icon
378
Navigator Holdings
NVGS
$1.28B
$627K 0.06%
44,343
-9,788
-18% -$132K
ETSY icon
379
Etsy
ETSY
$7.85B
$626K 0.06%
+12,484
New +$621K
RGLD icon
380
Royal Gold
RGLD
$19.5B
$624K 0.06%
+3,511
New +$622K
ETON icon
381
Eton Pharmaceutcials
ETON
$1.22B
$621K 0.06%
43,600
-125,836
-74% -$1.99M
ARIS
382
Aris Mining
ARIS
$3.59B
$621K 0.06%
92,353
+44,262
+92% +$263K
XPOF icon
383
Xponential Fitness
XPOF
$211M
$620K 0.06%
82,821
-30,625
-27% -$254K
TXG icon
384
10x Genomics
TXG
$6.61B
$615K 0.06%
+53,069
New +$484K
SU icon
385
Suncor Energy
SU
$70.3B
$605K 0.06%
16,165
-593
-4% -$21.4K
VERA icon
386
Vera Therapeutics
VERA
$2.36B
$603K 0.06%
+25,600
New +$576K
VIK icon
387
Viking Holdings
VIK
$47.2B
$600K 0.06%
11,258
-15,134
-57% -$668K
ACAD icon
388
Acadia Pharmaceuticals
ACAD
$5.03B
$593K 0.06%
+27,511
New +$511K
FLNG icon
389
FLEX LNG
FLNG
$1.67B
$590K 0.06%
26,858
-3,082
-10% -$72.2K
ETHA
390
iShares Ethereum Trust ETF
ETHA
$5.66B
$589K 0.06%
+30,887
New +$513K
MLI icon
391
Mueller Industries
MLI
$15.2B
$589K 0.06%
14,816
+6,598
+80% +$249K
FIVN icon
392
FIVE9
FIVN
$2.54B
$585K 0.06%
+22,100
New +$575K
SBS icon
393
Sabesp
SBS
$18.7B
$582K 0.06%
136,648
+46,749
+52% +$181K
SIMO icon
394
Silicon Motion
SIMO
$8.68B
$580K 0.06%
7,713
-1,452
-16% -$82.5K
PCRX icon
395
Pacira BioSciences
PCRX
$997M
$579K 0.06%
24,235
-104
-0.4% -$2.62K
SCHD icon
396
Schwab US Dividend Equity ETF
SCHD
$106B
$579K 0.06%
+21,854
New +$571K
EEM icon
397
iShares MSCI Emerging Markets ETF
EEM
$30B
$579K 0.06%
12,000
+1,334
+13% +$60K
JBS
398
JBS N.V.
JBS
$46.8B
$578K 0.06%
+39,568
New +$557K
TRUE
399
DELISTED
TrueCar
TRUE
$570K 0.06%
300,000
-65,914
-18% -$101K
CIEN icon
400
Ciena
CIEN
$58.4B
$569K 0.06%
+7,000
New +$502K
14 15
16
17 18

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.